Minerva Neurosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Minerva Neurosciences

25/02/2025 13:06

Minerva Neurosciences Inc NERV.OQ reported a quarterly adjusted loss of 56 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-1.39.  The lone analyst forecast for the quarter was for a loss of $1.05 per share.

Reported revenue was zero​; analysts expected zero.

Minerva Neurosciences Inc's reported EPS for the quarter was a loss of 56 cents​.

The company reported a quarterly loss of $4.27 million.

Minerva Neurosciences Inc shares had fallen by 19.4% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts was unchanged in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The average consensus recommendation for the biotechnology & medical research peer group is also "hold"

Wall Street's median 12-month price target for Minerva Neurosciences Inc is $5.00

This summary was machine generated from LSEG data February 25 at 01:06 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Dec. 31 2024
-1.05
-0.56
Beat
Sep. 30 2024
-1.01
-0.54
Beat
Jun. 30 2024
-0.97
-1.09
Missed
Mar. 31 2024
-1.20
-1.13
Beat